R C M Supplies LIMITED Partnership

R C M Supplies LIMITED Partnership is a woman-owned, for-profit business registered in Thailand with a current SAM.gov registration valid through May 6, 2026. Located in Bangkok at 3/1 Phahon Yothin 17 Alley, the company specializes in providing medical and laboratory supplies to federal agencies, with a particular focus on supporting research institutions. While limited background information is available, the company has demonstrated a consistent capability of supplying specialized medical and scientific equipment to U.S. military and defense-related research organizations.

The company has been awarded federal contracts primarily through the Defense Health Agency and the Chief of Naval Operations, focusing exclusively on medical and laboratory supply procurement. Specifically, R C M Supplies LIMITED Partnership has provided medical supplies and reagents to support the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. These contracts have ranged from specific purchase orders to broader blanket purchase agreements, with contract values between $11,287 and $16,883. None of the awards have utilized specific set-aside designations, suggesting the company competes on open contract opportunities. The contracts have been consistently short-term, ranging from five-day to multi-year performance periods, and are centered on supplying critical laboratory consumables and medical research materials.

R C M Supplies LIMITED Partnership holds a significant Blanket Purchase Agreement (BPA) with the Defense Health Agency, contract ID HT942524A0011, valued at $1,504,218.45 with a performance period through August 19, 2029. This single-award BPA is specifically designed for procuring laboratory plastics and consumables, providing a streamlined mechanism for the agency to acquire routine laboratory supplies. The BPA allows for flexible, as-needed ordering of laboratory materials, supporting the agency's research and operational requirements. While no specific contract vehicle is noted, the BPA represents a substantial long-term procurement arrangement that leverages the company's specialized supply capabilities in supporting medical and scientific research infrastructure.